| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
136,480,000 |
| Market
Cap: |
3.50(B) |
| Last
Volume: |
503,160 |
Avg
Vol: |
498,450 |
| 52
Week Range: |
$25.43 - $34.14 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
| |
NASDAQ COMPOSITE |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Perrigo is a provider of over-the-counter health and wellness solutions that can be self-managed. Co.'s segments are as follows: Consumer Self-Care Americas, which is focused primarily on the sale of self-care products in categories including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements; Consumer Self-Care International, which develops, manufactures, markets, and distributes European consumer self-care brands in the upper respiratory, pain and sleep-aids, digestive health, vitamins, minerals and supplements; and Prescription Pharmaceuticals, which develops, manufactures, and markets a portfolio of generic prescription drugs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Arkin Moshe |
Director |
– • – |
2008-09-03 |
4 |
S |
$34.90 |
$3,335,583 |
I/I |
(95,545) |
8,979,904 |
|
- |
|
| Arkin Moshe |
Director |
– • – |
2008-09-03 |
4 |
S |
$34.97 |
$13,989 |
I/I |
(400) |
8,979,504 |
|
- |
|
| Jandernoa Michael J |
Director |
– • – |
2008-09-02 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,788 |
2,887,227 |
|
- |
|
| Shah Jatin |
Sr VP & Chief Scientific Offic |
• – – |
2008-09-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
11,162 |
|
- |
|
| Jandernoa Michael J |
Director |
– • – |
2008-08-28 |
4 |
GD |
$0.00 |
$0 |
I/I |
87 |
2,889,015 |
|
- |
|
| Lebel Refael |
EVP & GM Perrigo Israel |
• – – |
2008-08-27 |
4 |
S |
$35.19 |
$281,712 |
D/D |
(8,000) |
21,208 |
|
- |
|
| Lebel Refael |
EVP & GM Perrigo Israel |
• – – |
2008-08-27 |
4 |
OE |
$14.69 |
$117,520 |
D/D |
8,000 |
29,208 |
|
- |
|
| Jandernoa Michael J |
Director |
– • – |
2008-08-26 |
4 |
GD |
$0.00 |
$0 |
I/I |
688 |
2,889,102 |
|
- |
|
| Jandernoa Michael J |
Director |
– • – |
2008-08-25 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,307 |
2,889,790 |
|
- |
|
| Hendrickson John T |
EVP Global Operations & Supply |
• – – |
2008-08-25 |
4 |
S |
$36.24 |
$83,713 |
D/D |
(2,309) |
5,441 |
|
- |
|
| Hendrickson John T |
EVP Global Operations & Supply |
• – – |
2008-08-25 |
4 |
S |
$35.92 |
$457,548 |
D/D |
(12,691) |
7,750 |
|
- |
|
| Hendrickson John T |
EVP Global Operations & Supply |
• – – |
2008-08-25 |
4 |
OE |
$9.84 |
$170,742 |
D/D |
15,000 |
20,441 |
|
- |
|
| Hendrickson John T |
EVP Global Operations & Supply |
• – – |
2008-08-25 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,000 |
45,595 |
|
- |
|
| Arkin Moshe |
Director |
– • – |
2008-08-25 |
4 |
S |
$36.00 |
$645,056 |
I/I |
(17,893) |
9,507,882 |
|
- |
|
| Jandernoa Michael J |
Director |
– • – |
2008-08-22 |
4 |
GD |
$0.00 |
$0 |
I/I |
3,506 |
2,891,097 |
|
- |
|
| Morris Herman Jr |
Director |
– • – |
2008-08-22 |
4 |
S |
$36.47 |
$118,131 |
D/D |
(3,238) |
16,405 |
|
- |
|
| Gibbons David T |
Director |
– • – |
2008-08-22 |
4 |
AS |
$35.90 |
$454,781 |
D/D |
(12,480) |
126,440 |
|
- |
|
| Gibbons David T |
Director |
– • – |
2008-08-22 |
4 |
AS |
$36.52 |
$92,072 |
D/D |
(2,520) |
123,920 |
|
- |
|
| Arkin Moshe |
Director |
– • – |
2008-08-22 |
4 |
S |
$36.06 |
$1,594,868 |
I/I |
(44,000) |
9,581,775 |
|
- |
|
| Arkin Moshe |
Director |
– • – |
2008-08-22 |
4 |
S |
$36.43 |
$2,042,973 |
I/I |
(56,000) |
9,525,775 |
|
- |
|
| Kingma Todd W |
Executive VP, General Counsel |
• – – |
2008-08-22 |
4 |
S |
$36.49 |
$342,485 |
D/D |
(9,385) |
30,432 |
|
- |
|
| Kingma Todd W |
Executive VP, General Counsel |
• – – |
2008-08-22 |
4 |
OE |
$13.90 |
$164,548 |
D/D |
9,825 |
39,817 |
|
- |
|
| Stewart Michael Robert |
Sr. VP Global Human Resources |
• – – |
2008-08-21 |
4 |
S |
$35.67 |
$305,174 |
D/D |
(8,550) |
6,559 |
|
- |
|
| Stewart Michael Robert |
Sr. VP Global Human Resources |
• – – |
2008-08-21 |
4 |
OE |
$13.90 |
$141,221 |
D/D |
8,906 |
15,109 |
|
- |
|
| Needham Jeffrey |
Sr. VP Commercial Business Dev |
• – – |
2008-08-21 |
4 |
S |
$35.24 |
$649,882 |
D/D |
(18,398) |
5,030 |
|
- |
|
1400 Records found
|
|
Page 37 of 56 |
|
|
0.08 (0.31%) 
